|
|
Article: Barr Laboratories Inc. (Woodcliff Lake NJ) won approval for a generic version of Nimotop, which prevents brain damage resulting from aneurysm or hemorrhage.(FDA ROUNDUP)(briefs)(United States. Food and Drug Administration)(Brief article)
- Article from:
- MondayMorning
- Article date:
- May 7, 2007
CopyrightCOPYRIGHT 2007 MedContent Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
FDA ROUNDUP: Barr Laboratories Inc. (Woodcliff Lake NJ) won approval for a generic version of Nimotop, which prevents brain damage resulting from aneurysm or hemorrhage. Elsewhere, GlaxoSmithKline PLC was cleared to sell its Veramyst Nasal Spray to treat seasonal and year-round allergy symptoms in adults and children 2-years-old and older. This is the first regulatory approval of fluticasone furoate nasal spray, which is also under review under the trade name Allermist in Japan and under the trade name Avamys in Europe, Canada, Australia and other international markets. InSite Vision Inc. (Alameda CA) won approval for its Azasite solution to treat common eye infections, such ...